Abstract The dystrophin-associated protein complex (DPC) consisting of syntrophin, dystrobrevin, and dystroglycan isoforms is associated either with dystrophin or its homolog utrophin. It is present not only in muscle cells, but also in numerous tissues, including kidney, liver, and brain. Using high-resolution immunofluorescence imaging and Western blotting, we have investigated the effects of utrophin and dystrophin gene deletion on the formation and membrane anchoring of the DPC in kidney epithelial cells, which co-express utrophin and low levels of the Cterminal dystrophin isoform Dp71. We show that multiple, molecularly distinct DPCs co-exist in the nephron; these DPCs have a segment-specific distribution and are only partially associated with utrophin in the basal membrane of tubular epithelial cells. In utrophin-deficient mice, a selective reduction of β2-syntrophin has been observed in medullary tubular segments, whereas α1-syntrophin and β1-syntrophin are retained, concomintant with an upregulation of β-dystroglycan, β-dystrobrevin, and Dp71. These findings suggest that β2-syntrophin is dependent on utrophin for association with the DPC, and that loss of utrophin is partially compensated by Dp71, allowing the preservation of the DPC in kidney epithelial cells. This hypothesis is confirmed by the almost complete loss of all DPC proteins examined in mice lacking full-length utrophin and all C-terminal dystrophin isoforms (utrophin 0/0 /mdx 3Cv ). The DPC thus critically depends on these proteins for assembly and/or membrane localization in kidney epithelial cells.
Introduction
The dystrophin-associated protein complex (DPC) is a multimeric membrane-spanning complex linked either to dystrophin, a large X-linked cytoskeletal protein, or to its autosomal homolog utrophin (Matsumura et al. 1992) . In skeletal muscle cells, the DPC is composed of α-dystroglycan (an extracellular protein bound to laminin), β-dystroglycan and sarcoglycans (spanning the membrane), and dystrobrevins and syntrophins (located intracellularly). Utrophin and dystrophin anchor this complex to the cytoskeleton by binding to the intracellular tail of β-dystroglycan and to actin filaments (Way et al. 1992; Winder et al. 1995) . Utrophin is selectively localized at the neuromuscular junction (NMJ), whereas dystrophin is present in the NMJ as well as along the inner face of the surface membrane, the sarcolemma. The DPC seems to contribute to the aggregation of acetylcholine receptors (AChRs) at the NMJ and to enhance the structural stability of the sarcolemma (Grady et al. 2000) . Association of signaling molecules, such as nitric oxide synthase, α5β1 integrin, and focal adhesion kinase, with the DPC also suggests a role in signal transduction (Bredt 1999; Hillier et al. 1999; Winder 2001) . Disruption of the DPC by mutations in its main components results in severe muscle dystrophies.
Dystrophin is expressed mainly in skeletal and cardiac muscle and in the brain (Mehler 2000; ). Short C-terminal dystrophin isoforms, ranging in size from 71 kDa to 260 kDa and lacking the actin-binding domain, have a more widespread distribution (Ahn and Kunkel 1993; Austin et al. 1995; Durbeej et al. 1997; Culligan et al. 1998; Lidov and Kunkel 1998; Blake et al. 1999 Lumeng et al. 1999; Chavez et al. 2000) . Mice lacking dystrophin and all its Cterminal isoforms including Dp71 (mdx 3Cv ) are viable, allowing the role of these proteins in non-muscle tissues to be investigated (Cox et al. 1993) . Utrophin has a ubiquitous expression pattern, with high levels in lung, kidney, liver, nervous system, and blood vessels (Love et al. 1993; Dixon et al. 1997; Grady et al. 1997a; Tinsley et al. 1998; Rafael et al. 1999; Knuesel et al. 2000; Loh et al. 2000; Raats et al. 2000; Regele et al. 2000; Zuellig et al. 2000; Jimenez-Mallebrera et al. 2003; Haenggi et al. 2004) . DPC proteins are molecularly heterogeneous, with the isoforms of each protein being encoded by distinct genes or being generated by alternative splicing or differential promoter usage. In particular, dystrobrevins, which are structurally homologous to dystrophin and utrophin, are encoded by two separate genes, α-dystrobrevin and β-dystrobrevin, the former being alternatively spliced into five distinct isoforms (Blake et al. 1996; Ambrose et al. 1997; Peters et al. 1997b; Nawrotzki et al. 1998; Newey et al. 2001) .
The syntrophin family likewise comprises several isoforms in muscle encoded by separate genes (α1, β1, β2) and two brain-specific genes (γ1 and γ2; Piluso et al. 2000; . Whereas sarcoglycans are muscle-specific , the dystrobrevin and syntrophin isoforms exhibit a differential tissue distribution and are selectively associated with either dystrophin or utrophin, suggesting the existence of several molecularly and functionally distinct DPCs in non-muscle cells.
Analysis of mice with targeted mutations has revealed the interdependence of the DPC with either utrophin or dystrophin for assembly in muscle. For instance, mice with dystroglycan-deficient skeletal muscles and mice lacking α-syntrophin show severely reduced levels of utrophin at the NMJ (Cote et al. 1999; Adams et al. 2000) . Conversely, α-dystrobrevins and the syntrophins disappear from the muscle sarcolemma in the absence of dystrophin (mdx mice) but are retained at the NMJ because of their association with utrophin (Deconinck et al. 1997; Grady et al. 1997a; Peters et al. 1997b ). The phenotype of utrophin 0/0 mice has not been investigated in detail. These mice are fertile and exhibit normal behavior and life span. Their NMJ are functionally not altered, although they contain fewer postsynaptic folds possibly because of decreased AChR density (Deconinck et al. 1997; Grady et al. 1997b) .
Little is known, however, about the assembly, cellular localization, and function of the DPC in non-muscle tissues. The issue is further complicated because these proteins are not readily detected in morphologically wellpreserved tissue, and the molecular composition of the DPC may be cell-type specific (Loh et al. 2000) .
The aim of the present study has been to investigate the role of utrophin and the short dystrophin isoform Dp71 for the assembly and subcellular localization of the DPC in the various kidney nephron segments. Dp71 has been reported to represent the main dystrophin isoform in kidney (Lumeng et al. 1999; Loh et al. 2000 Loh et al. , 2001 . The distribution of DPC proteins was analyzed by highresolution immunofluorescence staining in wild-type and mutant mice (utrophin 0/0 and utrophin 0/0 /mdx 3Cv ). Changes in their expression levels have been assessed by Western blotting experiments. The results reveal a distinct molecular heterogeneity of the DPC in the different segments of the nephron, identified with specific markers. The DPC exhibits a polarized distribution in the basal membrane of tubular epithelial cells in partial dependence on utrophin expression. However, in the absence of utrophin and all dystrophin isoforms in utrophin 0/0 /mdx 3Cv mice, the DPC is completely disrupted throughout the nephron, demonstrating that the assembly and/or membrane localization of the complex critically depends on utrophin and Dp71.
Materials and methods

Animals
Utrophin 0/0 mice were generated by crossing dystrophinutrophin double-mutants (mdx/utrophin 0/0 , generated on a mixed 129-C57Bl/6 background; Grady et al. 1997a) , with wild-type C57Bl/6 mice (Institute of Animal Science, University of Zurich) giving an F1 generation heterozygous for utrophin (utrophin +/0 ; males) or utrophin and dystrophin (mdx: utrophin +/0 ; females). Utrophin 0/0 mice were obtained by the crossbreeding of heterozygous or homozygous mice. Utrophin 0/0 /mdx 3Cv double-knockout mice were generated by crossing utrophin 0/0 mice with mdx 3Cv mice (Jackson Laboratories, Bar Harbor, Me., USA) giving an F1 generation heterozygous for utrophin (utrophin +/0 ; females) and hemizygous for dystrophin (mdx 3Cv ; males). Utrophin 0/0 /mdx 3Cv double-knockout mice were obtained by the crossbreeding of heterozygous mice. For genotyping, DNA from tail biopsies was analyzed by the polymerase chain reaction (PCR). The double-knockout mice lived only 3-4 weeks postpartum. They displayed severe muscle impairment and were smaller by one third than wild-type mice. All animal experiments were approved by the Cantonal Veterinary Office of Zurich. Kidney tissue of α1-syntrophin 0/0 mice was obtained from Dr. M. Adams, Chapel Hill, N.C., USA.
Immunoblotting
Kidney tissue from adult wild-type and utrophin 0/0 mice was homogenized in 1-2 volumes of ice-cold sucrose buffer (0.32 M sucrose, 10 mM TRIS/HCl pH 7.4, 5 mM EDTA, 0.02% NaN 3 , 0.2 mM phenylmethane sulfonylfluoride). The homogenate was then made up to ten volumes and centrifuged for 15 min at 1,000g. The supernatant was aliquoted and stored at −80°C.
Crude kidney fractions were subjected to SDS-polyacrylamide gel electrophoresis (SDS-PAGE) by using 4% stacking and 10% gradient resolving gels. Proteins were transferred onto nitrocellulose membranes (Bio Rad, Reinach, Switzerland) in an electro-blotting apparatus (Trans Blot, Bio Rad, Reinach, Switzerland) at 30 V overnight, at 4°C. For immunodetection, the blots were prepared as described by Knuesel et al. (2000) . To quantify changes in protein expression in utrophin 0/0 mice, Western blots were performed with tissue from four mutant and four wild-type animals, with actin as the internal standard.
Immunofluorescence staining
Cryostat sections (12 μm) prepared from fresh-frozen mouse kidney or striated muscle were mounted onto gelatin-coated glass slides, air-dried at room temperature for 30 s, and stored at −20°C. They were thawed at room temperature, immersed in a Petri dish containing 50 ml fixative solution composed of 0.5% paraformaldehyde, 5% Kryofix (Merck, Dietlikon, Switzerland) in 0.15 M phosphate buffer, pH 7.4, irradiated in a microwave oven (30 s at 480 W), and washed twice with phosphatebuffered saline (PBS).
The sections were then incubated overnight at 4°C with primary antibodies diluted in PBS containing 4% normal goat serum (Table 1) . Sections were washed extensively in PBS and incubated for 30 min at room temperature with secondary antibodies conjugated to Cy3 (1:500; Jackson ImmunoResearch, West Grove, Pa., USA) or Alexa 488 (1:1,000; Molecular Probes, Eugene, Ore., USA). Sections were washed again, air-dried, and cover-slipped with buffered glycerol.
In control experiments, preadsorption of primary antibodies with peptide antigen (1-10 μg/ml) resulted in a dose-dependent loss of specific immunoreactivity. In double-labeling experiments, omission of one of the primary antibodies during overnight incubation led to complete loss of signal with the corresponding secondary antibodies, indicating the absence of cross-reactivity.
Data analysis
Sections were visualized by epifluorescence microscopy (Zeiss; Jena, Germany), and images were recorded with a digital camera (Orca, Hamamatsu City, Japan). For high magnification imaging, sections were analyzed by laser scanning confocal microscopy (LSM 510 Meta, Zeiss, Jena, Germany) with sequential recording of doublelabeled sections to avoid bleed-through between channels. 
Results
Characterization of antibodies to syntrophin isoforms
Antibodies selectively recognizing α1-syntrophin, β1-syntrophin, or β2-syntrophin (Table 1) were raised by using peptide sequences derived from the first pleckstrinlike domain of rat syntrophin genes (Peters et al. 1994) as antigens. They were tested by immunofluorescence on rat diaphragm ( Fig. 1a ) and mouse skeletal muscle sections (Fig. 1b, c ). β2-Syntrophin immunoreactivity (IR) was most intense at the NMJ (Fig. 1a) , whereas β1-syntrophin IR and α1-syntrophin IR was found on the entire sarcolemma (Fig. 1b, c) and at the NMJ (not shown), as expected (Peters et al. 1997a; Adams et al. 2000) . In control experiments on kidney sections, specific immunofluorescence staining was abolished upon preadsorption of the antisera with their peptide antigen ( Fig. 1d-i ).
Molecular heterogeneity of the DPC in the nephron
A systematic comparison of the distribution of members of the DPC in relation to specific markers of the main segments of the tubular system revealed a unique pattern for each of these proteins, with a striking regional specificity (Figs. 2, 3, Table 2 ). Utrophin IR was heterogeneous in the cortex, with glomeruli and isolated tubular segments being most intensely stained (Fig. 2a) . These included the cortical thick ascending limbs, which were double-labeled for the Na Payne et al. 1995; Fig. 2b) , and connecting Fig. 1 Specificity test of syntrophin antisera in adult striated muscle a, b, c, and in kidney in the absence d, f, h or presence e, g, i of peptide antigen (5 μg/ml) for competition. Intense β2-syntrophin IR is seen at the neuromuscular junction (NMJ) in adult rat diaphragm (a), whereas β1-syntrophin and α1-syntrophin staining outlines the entire sarcolemma in mouse skeletal muscle (b, c) . In kidney, the distinct labeling of medullary tubular epithelial cells, outlining individual tubules, was abolished in preadsorption experiments with β2-syntrophin
tubules and collecting ducts, which were immunoreactive for aquaporin 2 (AQP2; Nielsen et al. 1993a; Fig. 2c ). In contrast, utrophin IR was weak in the proximal tubules, identified with aquaporin 1 (AQP1; Nielsen et al. 1993b; Fig. 2d) or the multidrug resistant-associated protein 2 (MRP2; not shown). A different pattern was observed in the medulla, where intense utrophin staining homogeneously labeled all tubular segments (Fig. 2e) . With the Fig. 2 Differential localization of utrophin (green) in major segments of the nephron identified with specific markers (red) in double-immunofluorescence experiments. Mouse kidney cryosections were stained for utrophin (utro), either alone (a, e) or in combination with one of the following markers:
, and laminin (k). Table 2 gives the distribution of these markers. The heterogeneous distribution of utrophin IR in the renal cortex (a) is seen at low magnification, with intense staining of glomeruli (arrowheads) and isolated tubules. Double-immunofluorescence images allow the identification of the tubules of the cortical thick ascending limbs (b) and connecting tubules (c), which are intensely stained for utrophin (green). In contrast, the proximal tubules (d) are only weakly stained for utrophin. In the medulla, utrophin IR is homogeneously distributed (e), with intense labeling of the thick ascending limbs (f), collecting ducts (g), and thin descending limbs (h). Vascular bundles, recognized by their intense MRP1 staining appear devoid of utrophin IR (i). Double-labeling with laminin (k) illustrates the close apposition of utrophinpositive membranes (green) with the basal lamina (red). Bars 200 μm (a, e, i),
same markers as above (Table 2) , utrophin IR was found in medullary thick ascending limbs, which were positive for NKCC2 (Fig. 2f) , in the collecting ducts, which were labeled with AQP2 (Fig. 2g) , in the descending thin limb of Henle's loop, which was labeled with AQP1-IR (Fig.  2h) , and in the ascending thin limbs, distal tubules, and collecting ducts, which were all labeled with MRP1 (Cordon-Cardo et al. 1989 ; not shown). The only medullary structures lacking utrophin IR were the vascular bundles, which exhibited prominent MRP1 IR (Fig. 2i) . At the subcellular level, double-staining with laminin revealed that the two markers were closely apposed but not colocalized (Fig. 2k) , suggesting that utrophin IR (green) was restricted to the basal membrane of tubular cells.
The three syntrophin isoforms were colocalized partially with utrophin, but each isoform had a unique distribution pattern (Table 2 ). In the cortex, β2-syntrophin IR was ubiquitous, being most intense in structures weakly labeled with utrophin, such as the proximal tubules (Table  2 ). In contrast, the two markers were colocalized in the medulla, outlining all tubules by a strong staining of the basal membrane (Fig. 3a) . Like utrophin IR, β2-syntrophin IR was also absent from the medullary vascular bundles. The β1-syntrophin antibody selectively labeled all utrophin-positive tubules in the cortex (Table 2) ; in the medulla, β1-syntrophin IR was heterogeneous, being intense in descending thin limbs and collecting ducts, but only weak in thick ascending limbs (Fig. 3b) . Finally, α1-syntrophin IR was heterogeneous in the cortex, being restricted to connecting tubules and collecting ducts and always colocalizing with utrophin (Table 2 ). In the medulla, α1-syntrophin IR differed from β1-syntrophin IR by weaker labeling of the thick ascending limbs and thin descending limbs (Fig. 3c) .
The dystrobrevin antibody revealed homogeneous intense staining in the cortex and a heterogeneous pattern in the medulla, with the thick ascending limbs being only weakly labeled (Fig. 3d, Table 2 ). Although this antibody recognized both α-dystrobrevin and β-dystrobrevin, previous studies indicated that β-dystrobrevin was predominantly expressed in kidney epithelial cells (Kachinsky et al. 1999; Loh et al. 2000 Loh et al. , 2001 , suggesting that the staining observed here mostly corresponded to this isoform. Taken together, these observations that show syntrophins and dystrobrevin were colocalized with utrophin in the medulla. They could also occur in cortical tubules devoid of utrophin staining (Table 2) , where they were presumably associated with dystrobrevin.
Finally, in line with the low abundance of β-dystroglycan and Dp71 reported in kidney (Austin et al. 1995; Durbeej et al. 1997; Tokarz et al. 1998; Durbeej and Campbell 1999; Lumeng et al. 1999; Loh et al. 2000) , Fig. 3 Subcellular distribution of DPC (red) proteins in medullary tubules of wild-type mice (a-f) in relation to utrophin (green), as seen by double-immunofluorescence staining. In the double-labeled panels, colocalization appears yellow. Homogeneous utrophin IR was detected in the basal membrane of medullary thick ascending limbs and collecting ducts, and in small capillaries in the interstitial tissue. Staining for most DPC proteins revealed a precise colocalization with utrophin IR (yellow), as shown for β2-syntrophin (a, β2-syn), β1-syntrophin (b, β1-syn), α1-syntrophin (c, α1-syn), pan-dystrobrevin (d, DB), and β-dystroglycan (e, β-DG). In contrast, Dp71 IR (f) was diffuse in the interstitial tissue but was not detectable in tubules, as seen by the lack of colocalization with utrophin (f). Tubules weakly labeled with β1-syntrophin, α1-syntrophin, and pan-dystrobrevin were medullary thick ascending limbs, whereas collecting ducts and descending thin limbs were intensely labeled. Note that no dystrobrevin IR was present in the interstitial tissue. Bar 20 μm immunofluorescence for these proteins appeared weak and diffuse in the nephron (Fig. 3e , f, Table 2 ). Only glomeruli and blood vessels were intensely stained. β-Dystroglycan staining was moderate in the vascular bundles and isolated capillaries but weaker in medullary tubules; it was however colocalized with utrophin IR (Fig. 3e) . Dp71 IR appeared as weak as β-dystroglycan staining (Fig. 3f) . However, at high resolution, Dp71 IR clearly outlined interstitial capillaries but was not detectable in the basal membrane of the thick ascending limbs and collecting ducts. The absence of dystrophin was confirmed by the lack of colocalization with utrophin (Fig. 3f) . Control experiments were performed in mdx 3Cv mice, in which no specific dystrophin IR was detected (not shown).
In the glomeruli, which stained intensively for both utrophin and Dp71, the two proteins did not colocalize (not shown). Utrophin IR was present in the Bowman's capsule and the intraglomerular convolutes, whereas Dp71 IR was absent from the capsule. The Dp71 antibody stained most prominently in regions toward the macula densa but also bound to intraglomerular structures, a result different from that for utrophin IR. This distribution suggested the presence of utrophin in capsular and intraglomerular epithelial cells and corresponded to electron-microscopic identification of utrophin in a granular podocyte-like staining pattern along the glomerular capillary walls (Raats et al. 2000; Regele et al. 2000) . On the other hand, Dp71 seemed to localize to the mesangial and/ or endothelial cells, similarly to a particular Dp71 splice variant, Dp71ΔC (Loh et al. 2000) . This differential distribution of utrophin and Dp71 corresponded to that observed in the utrophin-positive nephron segments. Glomeruli were not examined in further detail, because specific markers for the various cell types in the glomerulus were not identified, and because the secondary antimouse IgGs, used to detect monoclonal antibodies, produced a high background in these structures.
Alteration of the DPC in kidney of utrophin 0/0 mice
The role of utrophin for the formation of the DPC in the nephron was investigated by analyzing potential alterations in the subcellular distribution of DPC proteins in utrophin 0/0 mice ( Fig. 4a-h, Tables 3, 4) . The analysis was performed in the medulla, in which the distribution of utrophin was the most homogeneous. Sections from wildtype and mutant mice were processed in parallel under identical conditions and with the same reagents to minimize staining variability. In control experiments, no utrophin staining could be detected in sections from mutant mice, confirming the specificity of the antibody. Table 2 Distribution of DPC proteins in relation to markers (MRP1/2 multidrug resistant-associated protein 1/2, NKCC2 Na + /K + /Cl-cotransporter 2) of the renal tubules (ATL ascending thin limbs, CNT connecting tubules, CCT cortical collecting ducts, CTAL cortical thick ascending limbs, DTL descending thin limbs, MCT medullary collecting ducts, MTAL medullary thick ascending limbs, PT proximal tubules) and vasculature (BV blood vessels) as obtained by double-immunofluorescence staining. Signal intensities were assessed by visual inspection and ranged from background (−) to the most intense staining for each antibody (+++).
Marker
Renal tubules Vasculature β2-Syntrophin IR was markedly decreased in the medulla of utrophin 0/0 mice compared with that of the wild-type (Fig. 4a, b) . The remaining staining was still localized along the basal membrane of the epithelium in the absence of utrophin (Fig. 4b) . This change was highly specific, since β2-syntrophin IR remained unaltered in the Fig. 4 Alterations of DPC protein staining were assessed by using low-resolution confocal images of the renal medulla of wild-type (a, c, e, g), utrophin 0/0 (b, d, f, h), and utrophin 0/0 / mdx 3Cv (i-m) mice. The images illustrate the reduction of β2-syntrophin IR in utrophin 0/0 mice (a, b) in contrast to the unaltered β1-syntrophin IR and α1-syntrophin IR (c, d, and e, f, respectively) and to the enhanced dystrobrevin staining, which becomes almost homogeneous because of the increased labeling of the thick ascending limbs (g, h). In utrophin 0/0 /mdx 3Cv mice, the effects are much more pronounced, and an almost complete loss of staining is observed for β2-syntrophin (i), β1-syntrophin (k), and dystrobrevin (m). Note, however, that α1-syntrophin IR is only partially reduced in the collecting tubules (l) in the double-mutant mice. Bar 50 μm ) and utrophin 0/0 /mdx 3Cv (Dko) mice (ne not expressed, CCT cortical collecting ducts, MCT medullary collecting ducts, MTAL medullary thick ascending thin limbs, PT proximal tubules). Signal intensities of DPC proteins in specific renal segments were assessed by visual inspection and ranged from not changed (=), to decreased IR (↓), and to no detectable IR (↓↓) on the one hand, and to increased IR (↑) and to strongly increased IR (↑↑) on the other. 
β2-Syntrophin
cortex including the glomeruli (not shown), in particular in the proximal tubules in which it was normally not associated with utrophin. In striking contrast, no change in staining intensity or distribution could be observed for β1-syntrophin IR in mutant kidney compared with that of the wild-type (Fig. 4c, d ) in tubules of both the cortex and medulla. The same observation was made for α1-syntrophin IR, which was still present in the thick ascending limbs of utrophin-deficient kidney (Fig. 4e, f) . These results indicated an obligatory association of β2-syntrophin with utrophin in the membrane of medullary tubular epithelial cells, whereas β1-syntrophin and α1-syntrophin appeared independently of utrophin. The absence of utrophin also affected β-dystrobrevin staining, but in the opposite direction. Indeed, the heterogeneous labeling seen in the medulla of wild-type mice (Fig. 4g ) was replaced by intense homogeneous IR in all thick ascending limbs and collecting ducts (Fig. 4h) .
This result suggested that the DPC was partially maintained in the absence of utrophin, possibly by a compensatory increase of β-dystrobrevin IR. When visualized at high magnification, β-dystrobrevin staining clearly was enhanced at the surface of tubules in the utrophin 0/0 kidney compared with that of the wild-type (Fig. 5a, b) . The increased β-dystrobrevin IR therefore was used in doublelabeling experiments to determine the localization of β-dystroglycan and Dp71. The former was also increased in the medulla of utrophin 0/0 mice and was colocalized with β-dystrobrevin (Fig. 5c) . Even more striking was the pronounced Dp71 IR in the basal membrane of the collecting ducts and thick ascending limbs in utrophindeficient kidney; this IR was likewise colocalized with β-dystrobrevin IR (Fig. 5d) .
Changes in immunofluorescence staining between mutant and wild-type medulla were quantified by densitometry (Table 3 ). The measurements were confined to the basal membrane of medullary thick ascending limbs and collecting ducts. In wild-type, the cell surface was localized by using utrophin as the reference; in mutants, dystrobrevin IR was used. This analysis revealed an almost 50% decrease in β2-syntrophin IR in mutant kidney and confirmed that β1-syntrophin and α1-syntrophin staining remained unaltered. Dystrobrevindystroglycan IR and β-dystroglycan IR were increased by more than 20% and 50%, respectively, in mutant mice, whereas Dp71 IR had more than tripled (Table 3) . Taken together, these results indicated that the DPC normally associated with utrophin in medullary tubules had been replaced by a different complex containing β-dystroglycan, Dp71, dystrobrevin, β1-syntrophin, and α1-syntrophin.
Specific upregulation of Dp71 protein expression in utrophin 0/0 mice
The pronounced alterations in immunofluorescence staining observed in utrophin 0/0 mice raised the question as to whether they reflected a change in protein expression or in subcellular localization. Crude kidney extracts prepared from wild-type and utrophin-deficient mice were analyzed by Western blotting (Fig. 6, Table 3 ). We focused on β2-syntrophin, dystrobrevin, β-dystroglycan, and Dp71, which exhibited differential alterations in immunofluorescence staining. In these experiments, we could discriminate between α1-dystrobrevin and β-dystrobrevin isoforms based on their molecular weight and could show that β-dystrobrevin was more abundant than the α1 isoform (Fig. 6, left panel) , confirming previous studies (Blake et al. 1999; Loh et al. 2000) .
The increased dystrobrevin and β-dystroglycan immunofluorescence in sections from utrophin 0/0 kidney could not be replicated in the Western blots (Fig. 6, right panel) . Conversely, in spite of the profound reduction of β2-syntrophin immunofluorescence, no significant decrease was seen in Western blots (Fig. 6 ). However, a strong increase in Dp71 protein levels was observed (Fig. 6,  Table 3 ). A compensatory upregulation of this protein might therefore play a crucial role for the maintenance of the DPC in the absence of utrophin.
Disruption of the DPC in kidney of utrophin
To verify this hypothesis, we investigated the kidney of double-mutant mice (utrophin 0/0 /mdx 3Cv ) lacking both utrophin and all C-terminal dystrophin isoforms (Fig. 4i m, Table 4 ). Most strikingly, the staining of the DPC proteins investigated was largely abolished in tubular epithelial cells and in glomeruli, suggesting that the DPC was not formed in the nephron in the absence of utrophin and Dp71. These results, as illustrated for the medulla (Fig. 4i-m) , also provided indirect evidence for the specificity of our antibodies. Unexpectedly, however, α1-syntrophin IR was only partially decreased in medullary collecting ducts (Fig. 4l) , raising the question as to whether this protein existed alone or whether this staining was an artifact.
Therefore, immunofluorescence experiments were performed in α1-syntrophin 0/0 kidney (Adams et al. 2000) . The localization and intensity of the β2-syntrophin IR and β1-syntrophin IR appeared normal in these mice, in both cortex and medulla (Fig. 7) . However, the α1-syntrophin staining in the medulla disappeared only from the thick ascending limbs and was partially retained in the collecting ducts (Fig. 7m) , as also seen in utrophin 0/0 / mdx 3Cv mice (Fig. 4l ). This result indicated that the α1-syntrophin antibody was not totally specific in this segment of the nephron. Therefore, α1-syntrophin, like the other members of the DPC, did not remain in the cell membrane of tubular epithelial cells in the absence of utrophin and dystrophin. Caution had therefore to be applied to the interpretation of the immunofluorescence experiments, since the non-specific staining in collecting ducts produced by the α1-syntrophin antibody had not been revealed by the preadsorption experiments (Fig. 1i) . Semi-quantitative Western blotting of crude kidney extracts from wild-type and utrophin 0/0 mice. Lanes were loaded with 5, 10, and 20 μg protein (left to right) and probed with the antibodies indicated far right. α-Dystrobrevin-1 (α-DB-1; 78 kDa) and β-dystrobrevin (β-DB; 63 kDa) were both detected with the pandystrobrevin antibody (see Table 1 ). All lanes were also labeled with antibodies to actin as a control for protein loading and blotting efficiency. No difference in staining intensity was observed between genotypes for β2-syntrophin (β2-syn), β-dystroglycan (β-DG), α-dystrobrevin-1 (α-DB-1) and β-dystrobrevin (β-DB). In contrast, staining for Dp71 was markedly increased in the absence of utrophin. Note the low abundance of α-dystrobrevin compared with β-dystrobrevin in both genotypes. The results of the quantification are given in Table 3 .
Discussion
The present study provides morphological evidence for the existence of multiple, molecularly distinct DPCs in kidney tubular epithelial cells. This heterogeneity arises from the differential segment-specific distribution of utrophin, dystrobrevin, α1-syntrophin, and β1-syntrophin, whereas β2-syntrophin is present throughout the nephron, together with low levels of β-dystroglycan. In the kidney of utrophin-deficient mice, a profound reorganization takes place, with β2-syntrophin disappearing from the medullary segments, and Dp71 being upregulated and associated with increased levels of β-dystrobrevin and β-dystroglycan. This compensatory mechanism is lost in mice that lack both utrophin and C-terminal dystrophin isoforms and in which the DPC is disrupted throughout the nephron.
These findings reveal a complex interdependence among members of the DPC for assembly and cellmembrane expression. β2-Syntrophin is dependent on utrophin in the medulla but not in the cortex, whereas α1-syntrophin, β1-syntrophin, and dystrobrevin require Dp71 for cell membrane expression. In spite of its homology with dystrophin and utrophin, dystrobrevin cannot form a DPC in kidney tubular epithelial cells in the absence of these partners.
Organization of the DPC in the nephron
We have used segment-specific markers to investigate the organization of the DPC in the nephron and have carried out immunofluorescence experiments on sections weakly fixed by microwave irradiation to minimize loss of antigenicity following fixation (Fritschy et al. 1998 ). This procedure results in a strong specific immunofluorescence signal, while allowing satisfactory morphological preservation. In contrast, preliminary experiments in perfusion-fixed tissue have revealed only a low signalto-noise ratio for all DPC proteins tested. The issue of antibody specificity and sensitivity has been a major concern in this study. The almost complete loss of staining seen for all DPC proteins analyzed in double-mutant mice provides an indirect validation of the staining specificity. Although the α1-syntrophin antibody apparently recognizes an additional protein in collecting tubules, this marker is not associated with the cell membrane and does not invalidate our conclusions. With regard to the dystrobrevin isoforms, our results confirm the predominance of β-dystrobrevin over α-dystrobrevins (Fig. 6) . Since α-dystrobrevin-1 is present mainly in glomeruli and blood vessels (Loh et al. 2000 (Loh et al. , 2001 , and since α-dystrobrevin-2 is not expressed in kidney (Blake et al. 1996; Loh et al. 2001) , the present description of dystrobrevin IR therefore mainly corresponds to β-dystrobrevin.
Our approach has allowed the unambiguous identification of six distinct segments (proximal tubule, descending thin limb, ascending thin limb, thick ascending limb, connecting tubules, and collecting duct) in which the major DPC proteins have been detected (Table 2) . The glomerulus has not been analyzed in detail, because the various glomerular cell types could not be identified by Fig. 7 Specificity test of syntrophin antisera in renal cortex and medulla of wild-type (a, c, e, g, i, l) and α1-syntrophinknockout (α1-syntrophin 0/0 ) mouse kidney (b, d, f, h, k, m) . β2-Syntrophin (a-d), β1-syntrophin (e-h), and α1-syntrophin (i-m). β2-Syntrophin staining in the cortex (a, b) and medulla 8c, d) was identical in both genotypes. The same observation was made for β1-syntrophin staining (e-h). Unexpectedly, some α1-syntrophin IR was retained in cortical (i-k) and medullary (l, m) collecting ducts, whereas the labeling of the remaining structures, in particular the medullary thick ascending limbs was abolished. The antiserum therefore recognized another protein selectively in collecting ducts, in addition to α1-syntrophin. Bar 40 μm immunofluorescence. In all the staining combinations analyzed in tubular epithelial cells, DPC proteins are precisely colocalized with each other, suggesting that they are part of the same complex. The DPC is probably anchored in the basal membrane, as evidenced by the close apposition of utrophin and laminin. Thus, laminin probably plays an important role in determining the localization of the DPC.
A major finding of this study is that the molecular composition of the DPC is different in each of these six segments of the nephron, because of the differential expression of utrophin, α1-syntrophin, β1-syntrophin, β2-syntrophin, and dystrobrevin. The distal parts of the nephron exhibit strong staining for utrophin, dystrobrevin, and the three syntrophin isoforms. The thick ascending limbs contain mainly utrophin and β2-syntrophin. The proximal tubules mainly contain dystrobrevin together with β2-syntrophin and only little utrophin. The heterogeneity in the expression of the syntrophin isoforms and their differential pattern of coexpression with each other and with dystrobrevin suggest that the molecularly distinct DPCs fulfill distinct functions in the various segments of the nephron.
Finally, the present results confirm that Dp71 is expressed at low protein levels in normal kidney (Lumeng et al. 1999; Loh et al. 2000) . The antibody used is directed against the last 17 amino acid residues at the C-terminal of dystrophin and hence recognizes all dystrophin isoforms containing exon 78 (Austin et al. 1995) . In addition to Dp71, a larger C-terminal dystrophin isoform, Dp140, has been localized to the basal surface of the tubule epithelium (Lidov and Kunkel 1998) . Both Dp71 and Dp140 are reported to occur in kidney in splice variants missing exon 78 (Austin et al. 1995; Lidov and Kunkel 1997; Loh et al. 2000) . In both cases, the most C-terminal residues are different in the splice variants and are not recognized by the antibody used here. The splice variant of Dp71, called Dp71ΔC, has been reported to be abundant in the cortex, notably in the proximal tubules, connecting tubules, and collecting ducts (Loh et al. 2000) . No information is available concerning Henle's loop and the thick ascending tubules. Dp71ΔC could thus play a role in the assembly of the DPC in those segments of the nephron in which utrophin is scarce.
Alterations of the DPC in utrophin-deficient mice
The analysis of utrophin 0/0 mice has yielded three distinct results. (1) In the major parts of the nephron, including the proximal tubules, loop of Henle, and collecting ducts, the DPC is not affected by the loss of utrophin. This result could be explained either by the presence of Dp71ΔC or by the upregulation of Dp71. (2) In the thick ascending limb of the medullary tubules, the absence of utrophin leads to a profound reduction of β2-syntrophin IR; this is not a result of the disruption of the DPC, since the other syntrophin isoforms remain unchanged, and since dystrobrevin staining is enhanced. Therefore, in a DPC containing only low levels of dystrobrevin, β2-syntrophin appears to depend on utrophin for association with the DPC. (3) The loss of utrophin is compensated by the upregulation of Dp71 and increased staining for β-dystroglycan and β-dystrobrevin; the resulting DPC is molecularly distinct from that formed in wild-type mice, but its polarized distribution in the basal membrane is fully retained.
Our Western blot analysis demonstrates that only the expression of Dp71 is upregulated in utrophin 0/0 mice, whereas the total protein levels of dystrobrevin and syntrophins remain largely unchanged, in spite of the prominent changes in immunoreactivity observed. Although immunoblot analysis of the entire kidney lacks spatial selectivity, this observation points to the existence of an intracellular pool of DPC proteins, independent of the membrane-associated complex in epithelial cells. The absence of utrophin might merely change the affinity of DPC proteins for the complex, thereby shifting the equilibrium between the DPC and the intracellular pool. Apparently, the "unused" β2-syntrophin is not degraded, since this protein is present at comparable levels in wildtype and utrophin 0/0 mice.
Role of utrophin and Dp71 for the formation of the DPC
The classical model of the DPC in muscle cells postulates that dystrophin or utrophin is essential for the assembly of the complex, but that these two proteins are, at least in part, functionally interchangeable (Blake and MartinRendon 2002) . This view has mainly been derived from the analysis of mdx and mdx/utrophin 0/0 mice, which exhibit strongly reduced levels of dystrobrevins and syntrophins in the sarcolemma and the NMJ, and from the demonstration that the retention of dystrophin in utrophin 0/0 mice is sufficient to prevent any deleterious effects on other DPC proteins (Blake and Martin-Rendon 2002) . On the other hand, ablation of a DPC component such as α-dystrobrevin affects neither dystrophin nor utrophin, whereas the syntrophins are concomitantly reduced (Grady et al. 2000) . However, ablation of α1-syntrophin leads to the loss of utrophin at the NMJ, whereas β1-syntrophin in the sarcolemma and β2-syntrophin in the NMJ are significantly upregulated (Adams et al. 2000) . The role of syntrophins has further been examined in polarized epithelial cells in vitro, demonstrating the essential role of a highly conserved Cterminal domain for utrophin binding and membrane targeting (Kachinsky et al. 1999) .
In non-muscle cells, the situation is more complex, and no clear rules have yet emerged. Loh et al. (2000) have demonstrated that the absence of all dystrophin isoforms in mdx 3Cv mice has no effect on the distribution of DPC proteins, except that β2-syntrophin is profoundly reduced in glomeruli and cortical renal tubules. Furthermore, inactivation of the β-dystrobrevin gene results in a profound loss of Dp71 and syntrophins, whereas α-dystrobrevin and utrophin are not altered (Loh et al. 2001 ). Loh et al. (2001) have concluded that β-dystrobrevin represents a key organizer of the DPC in kidney.
All told, these results indicate that Dp71 and possibly other dystrophin isoforms, together with α-dystrobrevin and β-dystrobrevin, have different roles in muscle and non-muscle tissues with respect to the assembly of the DPC. It is not established, however, whether this disparity is attributable to functional differences between the isoforms, to differences in the molecular composition of the DPC (for instance, dystroglycan is less abundant in kidney than in muscle), or to potential redundancies with other DPC proteins. Our findings in double-mutant mice indicate that the DPC is disrupted in the absence of both dystrophin and utrophin. The implications may be that the mild changes seen in utrophin 0/0 mice are attributable to the presence of Dp71ΔC in the cortex and to the upregulation of Dp71 in the medulla. Furthermore, these results show that β-dystrobrevin, in spite of its homology with dystrophin and utrophin, cannot form a DPC without one of these partners. Recently, we have shown that both utrophin and Dp71 play an essential role for assembly of the DPC also in the cerebrospinal fluid-and blood brain barriers (Haenggi et al. 2004 ).
Functional consequences
Utrophin 0/0 /mdx 3Cv double-mutant mice do not exhibit a devastating pathology in non-muscle tissues (Rafael et al. 1999) . The DPC does not appear essential for normal embryogenesis and development of the kidney or presumably for its basic function in laboratory animals. This conclusion does not exclude impaired function under specific conditions and/or the activation of compensatory mechanisms to maintain the function of tubular epithelial cells. Indeed, Loh et al. (2001) have shown that the glucose/creatine ratio in urine samples from female β-dystrobrevin-deficient females mice is increased. Since the glucose transporter protein 1 is localized in the basolateral membrane of the epithelium of the renal collecting duct (Farrell et al. 1992) , the DPC may contribute to the anchoring of this transporter to the membrane of collecting ducts and possibly to the polarized distribution of a vast array of membrane proteins. In addition, the molecular heterogeneity of the DPC along the main segments of the nephron strongly suggests a functional specialization. Since syntrophins have the potential to bind to various proteins containing a PDZ-domain (Peters et al. 1997a; Albrecht and Froehner 2002) , the DPC may mediate specialized signaling functions in kidney epithelial cells. One might therefore expect alterations in signal transduction in utrophin 0/0 /mdx 3Cv mice.
Conclusions
The DPC has been localized to the basal membranes of the epithelial cells of the nephron, and its composition appears to differ specifically with respect to the various tubular segments. In the absence of utrophin, the DPC changes its composition and associates with Dp71, which seems to replace utrophin at the inner side of the cell membrane. Upon ablation of not only Dp71, but also all C-terminal dystrophin isoforms in addition to utrophin, the DPC disintegrates completely. The double-knockout mice studied display a fragile phenotype resulting in death after 3-4 weeks postpartum. Our new findings suggest that these animals, in addition to muscle disturbances, also suffer from impaired kidney function.
